ABOUT THIS FUND
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
PRICE
$39.49 ▲ UP 48.35% (+$73.38)—
No price history available for BTEC over this range.
HOLDINGS
TOP 1 OF 1 · 8.54% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
